Back to search

Article

Exploring the <i>in-situ</i> evolution of Nitrofurantoin resistance in clinically derived Uropathogenic <i>Escherichia coli</i> isolates

2022-07-20

Abstract excerpt

<h4>BACKGROUND</h4> Nitrofurantoin has been re-introduced as a first-choice antibiotic to treat uncomplicated acute urinary tract infections in England and Wales. Its mode of action involves initial reduction by nitroreductases, to generate electrophilic intermediates that inhibit protein and nucleic acid synthesis. Highly effective against common uropathogens such as Escherichia coli , its use is accompanied by...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3554ea17-cd2a-58e1-9e93-051a09a9c476
DOI
10.1101/2022.07.19.500598
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring the <i>in-situ</i> evolution of Nitrofurantoin resistance in clinically derived Uropathogenic <i>Escherichia coli</i> isolatesDOI 10.1101/2022.07.19.500598
Select a neighboring publication to make it the new centre.